ENTITY
Medy Tox Inc

Medy Tox Inc (086900 KS)

53
Analysis
Health CareSouth Korea
Medy-Tox Inc. is a biopharmaceutical company. The Company researches, develops and manufactures biopharmaceutical products using clostridium botulinum which is a microorganism toxin.
more
Refresh
30 Jan 2017 09:45

Whale Watching in the Korea Stock Market

There is an adage in the financial market that says, "Don't fight the FED." In the Korea Stock Market, there is an adage that says, "Don't fight...

Logo
245 Views
Share
31 Dec 2016 06:11

Korea Stock Market Monthly Recap #9 - (December 2016)

The economic hope post Trump win continued to play out in the global equity markets in December. Dow Jones Industrial Average was up 3.3% and...

Logo
459 Views
Share
26 Dec 2016 16:13

Free Cash Flow Remains King in Weeding Out the Winners and Losers

The Korean Stock Market remains surprisingly fundamental driven and free cash flow remains a fundamental factor that could help investors to weed...

Logo
262 Views
Share
23 Dec 2016 07:38

Weeding Out the Chaff for Portfolio Outperformance in 2017

Investors prefer companies that can consistently grow their sales and profits, at reasonable valuations. In this report, we selected 72 companies...

Logo
194 Views
Share
08 Dec 2016 08:24

MediSetter Interview: Insight on Opportunities in Asia's Healthcare Industry

Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's...

Share
x